Biocleave Overview

  • Founded
  • 2002

Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.35M

  • Investors
  • 5

Biocleave General Information

Description

Operator of an industrial biotechnology platform designed to exploit the protein production capabilities of versatile microbes. The company's platform uses fermentation to produce renewable butanol from feedstocks including corn and cellulosic feedstocks, enabling pharmaceutical companies to access renewable butanol used in paints, coatings, adhesives, inks, plastics, pharmaceuticals, household cleaners, and personal care products.

Contact Information

Formerly Known As
Green Biologics, Green Biotechnologies
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Industrial Chemicals
Other Chemicals and Gases
Primary Office
  • 154AH Brook Drive
  • Milton Park, Oxfordshire
  • Abingdon OX14 4SD
  • England, United Kingdom
+44 01235 000000

Biocleave Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocleave Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
25. Later Stage VC 02-Mar-2022 $1.35M 00.000 Completed Generating Revenue
24. Later Stage VC (Series 1) 21-Dec-2020 00.000 00.000 Completed Generating Revenue
23. Grant 01-Oct-2020 000.00 Completed Generating Revenue
22. IBO 01-Jan-2019 00000 Completed Generating Revenue
21. Later Stage VC 10-Oct-2018 000.00 00000 000.00 Completed Generating Revenue
20. Grant 01-Jun-2018 00000 00000 Completed Generating Revenue
19. Grant 01-Apr-2018 00000 00000 Completed Generating Revenue
18. Debt - General 31-Dec-2017 000.00 00000 Completed Generating Revenue
17. Grant 01-Sep-2017 $403K $160M Completed Generating Revenue
16. Grant 01-Aug-2017 $433K $160M Completed Generating Revenue
To view Biocleave’s complete valuation and funding history, request access »

Biocleave Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000,000 00.000000 00.0 00.0 00 00.0 0.000
Ordinary 00,000,000 00.000000 00.0 00.0 00 00.0 00.000
Ordinary 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
C1 Ordinary 00,000,000 00.000000 00.00 00.00 00 00.00 0.000
C1 Ordinary 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
B1 Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
B Ordinary 00,000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 1,116,750 $0.000131 $2.57 $2.57 1x $2.57 0.63%
B Ordinary 9,224,676 $0.000131 $2.14 $2.14 1x $2.14 5.18%
To view Biocleave’s complete cap table history, request access »

Biocleave Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an industrial biotechnology platform designed to exploit the protein production capabilities of versatile mi
Biotechnology
Abingdon, United Kingdom
14 As of 2023
00.000
0000000000 0 00.000

000000

strud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
000000000 000000000
Seattle, WA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

000000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea co
000000000 000000000
Clayton, MO
000 As of 0000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biocleave Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arzeda Venture Capital-Backed Seattle, WA 00 000.00 00000000000 000.00
0000000000 0000000 Corporation Clayton, MO 000 000000&0
0000 000000 000 Formerly VC-backed Missoula, MT 0 00.000 000000&0 00.000
000000 Formerly VC-backed Emeryville, CA 0000 00.000 0000000000.
000000000 Corporation Bagsvaerd, Denmark 0000 00000000
You’re viewing 5 of 8 competitors. Get the full list »

Biocleave Patents

Biocleave Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210189325-A1 Processes involving clostridium saccharoperbutylacetonicum Active 13-Oct-2017 00000000
US-11584914-B2 Processes for producing organic solvents using clostridium saccharoperbutylacetonicum Active 13-Oct-2017 00000000 00
EP-3694983-A1 Processes involving clostridium saccharoperbutylacetonicum Pending 13-Oct-2017 00000000
GB-201716845-D0 Process Inactive 13-Oct-2017 00000000
GB-201816751-D0 Process Inactive 13-Oct-2017 C12N1/20
To view Biocleave’s complete patent history, request access »

Biocleave Executive Team (15)

Name Title Board Seat Contact Info
Elizabeth Jenkinson Ph.D Chief Executive Officer & Board Member
Karen Stanley Board Member and Finance Director
Sean Sutcliffe Chairman
You’re viewing 3 of 15 executive team members. Get the full list »

Biocleave Board Members (16)

Name Representing Role Since
David Denny Self Board Member 000 0000
Elizabeth Jenkinson Ph.D Biocleave Chief Executive Officer & Board Member 000 0000
Karen Stanley Biocleave Board Member and Finance Director 000 0000
Sean Sutcliffe Biocleave Chairman 000 0000
You’re viewing 4 of 16 board members. Get the full list »

Biocleave Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biocleave Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Egle B. Thomas Angel (individual) Minority 000 0000 000000 0
Longwall Ventures Venture Capital Minority 000 0000 000000 0
Wren Capital Angel Group Minority 000 0000 000000 0
Tennenbaum Capital Partners Asset Manager Minority 000 0000 000000 0
Convergence Group Corporation Minority 000 0000 000000 0
To view Biocleave’s complete investors history, request access »

Biocleave Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 00 00 23-Dec-2014 0000000000 Industrial Chemicals 0000 0000
Butylfuel 20-Jan-2012 Merger/Acquisition Environmental Services (B2B)
To view Biocleave’s complete acquisitions history, request access »